A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19

R Lockard, KC Priest, J Gregg… - Substance …, 2022 - journals.sagepub.com
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …
被引用次数：27 相关文章

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.

R Lockard, KC Priest, J Gregg… - Substance …, 2022 - search.ebscohost.com
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19

R Lockard, KC Priest, J Gregg, BM Buchheit - Substance Abuse, 2022 - Taylor & Francis
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19

R Lockard, KC Priest, J Gregg… - Substance …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19

R Lockard, KC Priest, J Gregg… - Substance …, 2022 - ohsu.elsevierpure.com
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.

R Lockard, KC Priest, J Gregg, BM Buchheit - Substance Abuse, 2022 - europepmc.org
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …